Anecortave

Chemical formula: C₂₃H₃₀O₅  Molecular mass: 344.451 g/mol  PubChem compound: 7074810

Active ingredient description

Anecortave, a synthetic cortisone, has been shown to have antiangiogenic properties that have been established in multiple experimental models of angiogenesis. Anecortave is under investigation to treat exudative age-related macular degeneration (AMD). Although similar in chemical structure to the corticosteroid hydrocortisone acetate, it possesses no glucocorticoid activity.

Medicine classification

This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:

ATC code Group title Classification
S01LA02 Anecortave S Sensory organs → S01 Ophthalmologicals → S01L Ocular vascular disorder agents → S01LA Antineovascularisation agents
Discover more medicines within S01LA02

Structural formula

Graphic representation of the active ingredient's molecular structure

External identifiers

CAS Substance: 10184-70-0
CAS Substance: 7753-60-8
DrugBank Drug: DB12081
KEGG Drug: D01733
PubChem Compound: 7074810
UNII Identifier: R5Y8O51589
ANECORTAVE

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.